Literature DB >> 26354518

Engagement in the HIV Care Continuum among Key Populations in Tijuana, Mexico.

Laramie R Smith1, Thomas L Patterson2, Carlos Magis-Rodriguez3, Victoria D Ojeda4, Jose Luis Burgos4, Sarah A Rojas5, María Luisa Zúñiga6, Steffanie A Strathdee4.   

Abstract

In Tijuana, Mexico, HIV is concentrated in sub-epidemics of key populations: persons who inject drugs (PWID), sex workers (SW), and men who have sex with men (MSM). To date, data on engagement in the HIV care continuum among these key populations, particularly in resource-constrained settings, are sparse. We pooled available epidemiological data from six studies (N = 3368) to examine HIV testing and treatment uptake in these key populations; finding an overall HIV prevalence of 5.7 %. Of the 191 identified HIV-positive persons, only 11.5 % knew their HIV-positive status and 3.7 % were on ART. Observed differences between these HIV-positive key populations suggest PWID (vs. non-PWID) were least likely to have previously tested or initiate HIV care. MSM (vs. non-MSM) were more likely to have previously tested but not more likely to know their HIV-positive status. Of persons aware of their HIV-positive status, SW (vs. non-SW) were more likely to initiate HIV care. Findings suggest engagement of key populations in HIV treatment is far below estimates observed for similarly resource-constrained generalized epidemics in sub-Saharan Africa. These data provide one of the first empirical-snapshots highlighting the extent of HIV treatment disparities in key populations.

Entities:  

Keywords:  HIV Continuum of Care; HIV testing; Key populations; Secondary HIV prevention

Mesh:

Year:  2016        PMID: 26354518      PMCID: PMC4785089          DOI: 10.1007/s10461-015-1186-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  30 in total

1.  Delayed entry into HIV medical care after HIV diagnosis: risk factors and research methods.

Authors:  Samuel M Jenness; Julie E Myers; Alan Neaigus; Julie Lulek; Michael Navejas; Shavvy Raj-Singh
Journal:  AIDS Care       Date:  2012-02-09

Review 2.  Mobility and HIV in Central America and Mexico: a critical review.

Authors:  Shira M Goldenberg; Steffanie A Strathdee; Maria D Perez-Rosales; Omar Sued
Journal:  J Immigr Minor Health       Date:  2012-02

Review 3.  What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.

Authors:  Louisa Degenhardt; Bradley M Mathers; Andrea L Wirtz; Daniel Wolfe; Adeeba Kamarulzaman; M Patrizia Carrieri; Steffanie A Strathdee; Kasia Malinowska-Sempruch; Michel Kazatchkine; Chris Beyrer
Journal:  Int J Drug Policy       Date:  2013-09-04

Review 4.  Global epidemiology of HIV among female sex workers: influence of structural determinants.

Authors:  Kate Shannon; Steffanie A Strathdee; Shira M Goldenberg; Putu Duff; Peninah Mwangi; Maia Rusakova; Sushena Reza-Paul; Joseph Lau; Kathleen Deering; Michael R Pickles; Marie-Claude Boily
Journal:  Lancet       Date:  2014-07-22       Impact factor: 79.321

5.  Vital signs: HIV prevention through care and treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

6.  Establishing a binational student-run free-clinic in Tijuana, Mexico: a model for US-Mexico border states.

Authors:  Victoria D Ojeda; Amy Eppstein; Remedios Lozada; Adriana C Vargas-Ojeda; Steffanie A Strathdee; David Goodman; Jose L Burgos
Journal:  J Immigr Minor Health       Date:  2014-06

7.  [Relationship between physicians and HIV patients: influence on adherence and quality of life].

Authors:  Cristina Herrera; Lourdes Campero; Marta Caballero; Tamil Kendall
Journal:  Rev Saude Publica       Date:  2008-04       Impact factor: 2.106

8.  Global HIV epidemiology: A guide for strategies in prevention and care.

Authors:  Sten H Vermund
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

9.  Effective access to health care in Mexico.

Authors:  Juan Pablo Gutiérrez; Sebastián García-Saisó; Germán Fajardo Dolci; Mauricio Hernández Ávila
Journal:  BMC Health Serv Res       Date:  2014-04-23       Impact factor: 2.655

10.  Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico.

Authors:  Steffanie A Strathdee; Remedios Lozada; Robin A Pollini; Kimberly C Brouwer; Andrea Mantsios; Daniela A Abramovitz; Tim Rhodes; Carl A Latkin; Oralia Loza; Jorge Alvelais; Carlos Magis-Rodriguez; Thomas L Patterson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

View more
  15 in total

1.  Drugs, discipline and death: Causes and predictors of mortality among people who inject drugs in Tijuana, 2011-2018.

Authors:  Brooke S West; Daniela A Abramovitz; Patricia Gonzalez-Zuniga; Gudelia Rangel; Dan Werb; Javier Cepeda; Leo Beletsky; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2019-11-24

2.  Prevalence and Correlates of Injecting with Visitors from the United States Among People Who Inject Drugs in Tijuana, Mexico.

Authors:  A Bórquez; R S Garfein; D Abramovitz; L Liu; L Beletsky; D Werb; S R Mehta; G Rangel; C Magis-Rodríguez; P González-Zúñiga; S A Strathdee
Journal:  J Immigr Minor Health       Date:  2019-12

3.  Impact of Public Safety Policies on Human Immunodeficiency Virus Transmission Dynamics in Tijuana, Mexico.

Authors:  Sanjay R Mehta; Antoine Chaillon; Tommi L Gaines; Patricia E Gonzalez-Zuniga; Jamila K Stockman; Horatio Almanza-Reyes; Jose Roman Chavez; Alicia Vera; Karla D Wagner; Thomas L Patterson; Brianna Scott; Davey M Smith; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

4.  "He is the Same as Me": Key Populations' Acceptability and Experience of a Community-Based Peer Navigator Intervention to Support Engagement in HIV Care in Tijuana, Mexico.

Authors:  Teresita Rocha-Jiménez; Eileen V Pitpitan; Rebeca Cazares; Laramie R Smith
Journal:  AIDS Patient Care STDS       Date:  2021-10-19       Impact factor: 5.078

5.  Behavioral and Psychosocial Correlates of HIV Testing Among Male Clients of Female Sex Workers in Tijuana, Mexico.

Authors:  Paul J Fleming; Thomas L Patterson; Claudia V Chavarin; Shirley J Semple; Carlos Magis-Rodriguez; Eileen V Pitpitan
Journal:  AIDS Behav       Date:  2017-08

6.  Uptake of a Partner Notification Model for HIV Among Men Who Have Sex With Men and Transgender Women in Tijuana, Mexico.

Authors:  Shirley J Semple; Heather A Pines; Steffanie A Strathdee; Alicia Harvey Vera; Gudelia Rangel; Carlos Magis-Rodriguez; Thomas L Patterson
Journal:  AIDS Behav       Date:  2018-07

7.  Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis.

Authors:  Lara K Marquez; Javier A Cepeda; Annick Bórquez; Steffanie A Strathdee; Patricia E Gonzalez-Zúñiga; Clara Fleiz; Claudia Rafful; Richard S Garfein; Susan M Kiene; Stephanie Brodine; Natasha K Martin
Journal:  Int J Drug Policy       Date:  2020-03-09

8.  Correlates of trichomoniasis among female sex workers who inject drugs in two Mexico-US border cities.

Authors:  Brooke S West; Milagros Becerra Ramirez; Claire C Bristow; Daniela A Abramovitz; Alicia Vera; Hugo Staines; M Gudelia Rangel; Thomas L Patterson; Steffanie A Strathdee
Journal:  Int J STD AIDS       Date:  2020-07-05       Impact factor: 1.456

9.  Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.

Authors:  Javier A Cepeda; Annick Bórquez; Christopher Magana; Anh Vo; Claudia Rafful; Gudelia Rangel; María E Medina-Mora; Steffanie Strathdee; Natasha K Martin
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

10.  Perceived Need and Acceptability of a Community-Based Peer Navigator Model to Engage Key Populations in HIV Care in Tijuana, Mexico.

Authors:  Eileen V Pitpitan; Maria Luisa Mittal; Laramie R Smith
Journal:  J Int Assoc Provid AIDS Care       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.